Psychological Well-Being of Patients with Moderate-to-Severe Plaque Psoriasis Treated with Tildrakizumab: 28-Week Interim Results from a Multicenter Observational Study in Italy Using the DASS-21 Questionnaire, the BLUE Study.

Trovato E, Bonifati C, Ribero S, Scalvenzi M, Narcisi A, Cuccia A, Panasiti V, Richetta AG, Pagnanelli G, Peris K, Rongioletti F, Satolli F, Bardazzi F, Borghi A, Carrera C, Galluzzo M, Lasagni C, Moretti G, Romanelli M, Cozzani E, Guarneri C, Venturini M, Bongiorno MR, Prignano F, Di Lernia V, Taviti F, Persechino S, De Pasquale R, Colonna F, Talamonti M, Costanzo A

Open source

DOI: 10.1007/s13555-026-01676-3
Published: 2026 Mar
Container: Dermatology and therapy
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s13555-026-01676-3,
  title = {Psychological Well-Being of Patients with Moderate-to-Severe Plaque Psoriasis Treated with Tildrakizumab: 28-Week Interim Results from a Multicenter Observational Study in Italy Using the DASS-21 Questionnaire, the BLUE Study.},
  author = {Trovato E and Bonifati C and Ribero S and Scalvenzi M and Narcisi A and Cuccia A and Panasiti V and Richetta AG and Pagnanelli G and Peris K and Rongioletti F and Satolli F and Bardazzi F and Borghi A and Carrera C and Galluzzo M and Lasagni C and Moretti G and Romanelli M and Cozzani E and Guarneri C and Venturini M and Bongiorno MR and Prignano F and Di Lernia V and Taviti F and Persechino S and De Pasquale R and Colonna F and Talamonti M and Costanzo A},
  year = {2026},
  journal = {Dermatology and therapy},
  doi = {10.1007/s13555-026-01676-3},
  url = {https://doi.org/10.1007/s13555-026-01676-3}
}

RIS

TY  - JOUR
TI  - Psychological Well-Being of Patients with Moderate-to-Severe Plaque Psoriasis Treated with Tildrakizumab: 28-Week Interim Results from a Multicenter Observational Study in Italy Using the DASS-21 Questionnaire, the BLUE Study.
AU  - Trovato E
AU  - Bonifati C
AU  - Ribero S
AU  - Scalvenzi M
AU  - Narcisi A
AU  - Cuccia A
AU  - Panasiti V
AU  - Richetta AG
AU  - Pagnanelli G
AU  - Peris K
AU  - Rongioletti F
AU  - Satolli F
AU  - Bardazzi F
AU  - Borghi A
AU  - Carrera C
AU  - Galluzzo M
AU  - Lasagni C
AU  - Moretti G
AU  - Romanelli M
AU  - Cozzani E
AU  - Guarneri C
AU  - Venturini M
AU  - Bongiorno MR
AU  - Prignano F
AU  - Di Lernia V
AU  - Taviti F
AU  - Persechino S
AU  - De Pasquale R
AU  - Colonna F
AU  - Talamonti M
AU  - Costanzo A
PY  - 2026
JO  - Dermatology and therapy
DO  - 10.1007/s13555-026-01676-3
UR  - https://doi.org/10.1007/s13555-026-01676-3
ER  -

APA

E, T., C, B., S, R., M, S., A, N., A, C., V, P., AG, R., G, P., K, P., F, R., F, S., F, B., A, B., C, C., M, G., C, L., G, M., M, R., E, C., C, G., M, V., MR, B., F, P., V, D. L., F, T., S, P., R, D. P., F, C., M, T., & A, C. (2026). Psychological Well-Being of Patients with Moderate-to-Severe Plaque Psoriasis Treated with Tildrakizumab: 28-Week Interim Results from a Multicenter Observational Study in Italy Using the DASS-21 Questionnaire, the BLUE Study.. Dermatology and therapy. https://doi.org/10.1007/s13555-026-01676-3

Source records

pubmed · retrieved 2026-09-27T01:12:22.724Z